financetom
Business
financetom
/
Business
/
Rolls-Royce denies report of IPO plans for small nuclear reactor unit
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Rolls-Royce denies report of IPO plans for small nuclear reactor unit
Aug 30, 2025 11:19 AM

(Reuters) -Rolls-Royce Holdings on Saturday denied a report it was exploring an initial public offering for its small nuclear reactor unit.

The Financial Times, citing people familiar with the situation, reported on Saturday the company was considering an IPO as well as other funding options. It said talks with investment houses and banks were at an early stage.

"Rolls-Royce SMR is not planning for, or in the process of launching, an initial public offering," a spokesperson for the unit said in an emailed statement to Reuters.

In June, the Rolls-Royce SMR unit was selected to build Britain's first Small Modular Reactors as part of its plan to speed up the decarbonisation of the power network from the mid-2030s. The unit, majority-owned by the British engineering firm, plans to build three reactors. 

The British government pledged 2.5 billion pounds ($3.4 billion) for the SMR programme over the next four years, aiming to launch one of Europe's first small-scale nuclear industries.

Countries including the United States, Canada, Romania and the Czech Republic are also pursuing SMRs, which could open a large global market if the British project succeeds. 

($1 = 0.7402 pounds)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Why Is Phio Pharmaceuticals Stock Soaring Today?
Why Is Phio Pharmaceuticals Stock Soaring Today?
Nov 3, 2025
Shares of Phio Pharmaceuticals Corp. ( PHIO ) are rising Monday after the company provided an update on an ongoing medical trial. PHIO is charging ahead with explosive momentum. Track the action here. What To Know: Clinical-stage siRNA biopharmaceutical company Phio Pharmaceuticals announced the pathologic results for three patients with cutaneous squamous cell carcinoma (cSCC) who completed treatment in the fifth and...
Sable Stock Slides As Insider Leak Claims Rock CEO And Phil Mickelson
Sable Stock Slides As Insider Leak Claims Rock CEO And Phil Mickelson
Nov 3, 2025
There is a fast-unfolding controversy involving Sable Offshore Corp. ( SOC ) , an Exxon Mobil Corp. ( XOM ) spin-off, centered on potentially leaked insider information and financial pressures. Sable shares tumbled Monday as new developments came to light.  SOC stock is tumbling. See the real-time price action here.  Last Friday, Hunterbrook published a report alleging that Sable's CEO...
Hippocratic AI valued at $3.5 billion in latest financing round
Hippocratic AI valued at $3.5 billion in latest financing round
Nov 3, 2025
Nov 3 (Reuters) - Hippocratic AI raised $126 million in its latest funding round led by Avenir Growth, it said on Monday, valuing the healthcare company at $3.5 billion and underscoring venture capital's strong interest towards artificial intelligence-integrated companies. Private funding has remained strong, as companies keep getting valued in billions by startup investors looking to capture the AI rush....
Boqii Shares Rise After $4.2 Million Registered Direct Offering
Boqii Shares Rise After $4.2 Million Registered Direct Offering
Nov 3, 2025
01:21 PM EST, 11/03/2025 (MT Newswires) -- Boqii ( BQ ) shares jumped 21.8% in recent trading Monday after the company announced a registered direct offering expected to raise $4.2 million in gross proceeds. Under the offering, Boqii ( BQ ) will sell 1.5 million class A shares or pre-funded warrants at $2.80 per share, with the warrants exercisable at...
Copyright 2023-2026 - www.financetom.com All Rights Reserved